お知らせ

Nakamura H and Takei M

Special Issue ‘Viral Infection and Autoimmune Diseases’

Viruses (IF5.818)

Iriyama N, Miura K, Takahashi H, Nakagawa M, Iizuka K, Hamada T, Koike T, Kurihara K, Endo T, Nakayama T, Hatta Y, Nakamura H

Clinical entity of cytomegalovirus disease in patients with malignant lymphoma on bendamustine therapy: a single-institution experience.

Leukemia and Lymphoma(IF2.996)

中村英樹　日本臨牀　特集シェーグレン症候群　ー診断・治療の最新動向ー（単著）　p1654-1660、2022年10月、日本臨牀社

Iizuka K, Morishita S, Nishizaki Y, Iizuka Y, Iriyama N, Ochiai T, Yanagisawa N, Yasuda H, Ando J, Gotoh A, Takei M, Hatta Y,  Nakamura H, Nakayama T, Komatsu N

Von Willebrand factor activity levels are influenced by driver mutation status in polycythemia vera and essential thrombocythemia patients with well-controlled platelet counts

Takei M, Kitamura N, Nagasawa Y, Tsuzuki H, Iwata M, Nagatsuka Y, Imai K, Fujiwara S,

Nakamura H

Are viral infections key inducers of autoimmune diseases?-Focus on Epstein-Barr virus-
Viruses, accepted (IF: 5.818)

• 中村英樹　Sjögren症候群　リウマチ病学テキスト、p209-17, 2022年5月、南江堂

• 八田善弘　専門医のための血液学（共著）、2022年3月、医学書院

• Takahashi H, Miura K, Nakagawa M. et al.　 Pirarubicin-based intensive chemotherapy followed by consolidative high-dose chemotherapies for peripheral T-cell lymphomas: A noncomparative phase 2 study.　 Hematol Oncol. Online ahead of print.
• Tsuboi H, Nakamura H, Takei M et al. Abatacept Ameliorates Both Glandular and Extraglandular Involvements in Patients With Sjögren’s Syndrome Associated with Rheumatoid Arthritis: Findings from an Open-Label, Multicenter, 1-Year, Prospective Study: the ROSE (Rheumatoid Arthritis with Orencia Trial Toward Sjögren’s Syndrome Endocrinopathy) and ROSE II trials. Mod Rheumatol. Online ahead of print.
• Nakamura H, Nagasawa Y, Kobayashi H. et al.　 Successful Treatment of SARS-CoV-2 Vaccination-related Activation of Rheumatoid Arthritis with Positive Findings for Epstein-Barr Virus.　Intern Med. 2022 Jul 1;61(13):2073-2076.
• Miura K, Takahashi H, Nakagawa M. et al.　 Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma.　 Expert Rev Anticancer Ther. 2022 Jun;22(6):583-595.
• Asatani S, Kobayashi H, Nagasawa Y. et al.　 Successful treatment for eosinophilic granulomatosis with polyangiitis causing severe myocarditis followed by cardiac magnetic resonance.　Mod Rheumatol Case Rep. 2022 Jun 24;6(2):248-253.
• Iriyama N, Miura K, Uchino Y. et al.　 Relationship between Carnitine Deficiency and Tyrosine Kinase Inhibitor Use in Patients with Chronic Myeloid Leukemia.　Chemotherapy. 2022;67(2):96-101.
• Nakamura H, Tsukamoto M, Nagasawa Y. et al.　 Does HTLV-1 Infection Show Phenotypes Found in Sjögren’s Syndrome?　Viruses. 2022 Jan 6;14(1):100.
• Tsutsumi D, Hayama T, Miura K, et al. A novel rituximab administration protocol to minimize infusion-related adverse reactions in patients with B-cell lymphoma. Int J Clin Pharm. 2022 Apr;44(2):366-373.
• Yasuda T, Sanada M, Kawazu M, et al. Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutation. Blood. 2022 Mar 24;139(12):1850-1862.
• Sugiura I, Doki N, Hata T, et al. Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood Adv. 2022 Jan 25;6(2):624-636.